flanders.bio is an independent life sciences cluster organisation based in Flanders, Belgium

flanders.bio is a dynamic, member driven organisation with currently more than 350 members from Belgium and abroad. We help our members to create value by organising Networking and Training Activities, supporting Internationalisation, providing Services and building Expertise. flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.

News from flanders.bio and its members

EMA Accepts Richter’s Marketing Authorization Application (MAA) for Estelle®, a Novel Combined Oral Contraceptive

Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announced that the European Medicines Agency (EMA) has accepted Gedeon Richter’s (hereinafter: “Richter”) regulatory submission for Estelle®, a combined oral contraceptive containing estetrol (E4) and drospirenone.

Patients | 27 February 20 Read more

iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers

26 February 20 Read more

MDxHealth Reports Financial Year 2019 Results and Provides Outlook for 2020

Conference call with Q&A today at 09:00 CET / 08:00 GMT, details provided below

26 February 20 Read more

Imec ontwikkelt kleine radiozender voor elektronische pil

Radio die meetgegevens over gezondheid binnenin het lichaam naar buiten kan communiceren werd voorgesteld op gerenommeerde internationale conferentie.


flanders.bio events, trainings & international missions

Strategic Partners